Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P31749 (
AKT
)
22,954
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
miRNAs play important roles in lung adenocarcioma (LADC) progression. We previously found that miR-1290 expression was upregulated in LADC tissue and serum samples from patients with LADC, and correlated with prognosis. However, the biological role of miR-1290 in LADC and mechanism of such role are poorly understood. Here, we found that miR-1290 overexpression promoted LADC cell proliferation, cell cycle progression and invasion, while suppressing cell apoptosis
in vitro
. Furthermore, miR-1290 promoted tumor growth, invasion and metastasis
in vivo
. miR-1290 downregulated
suppressor of cytokine signaling 4
(
SOCS4
) at both the mRNA and protein levels by targeting
SOCS4
. Reduced
SOCS4
level reversed the inhibitory effect of miR-1290 downregulation on cell proliferation and invasion. miR-1290 activated the JAK/STAT3 and PI3K/
AKT
signaling pathways by targeting
SOCS4
. An inverse correlation was observed between miR-1290 and
SOCS4
expression in LADC tissues. Clinicopathological characteristics analysis showed that
SOCS4
expression was negatively associated with higher clinical stage and lymph node metastasis. These observations suggest that miR-1290 promotes LADC cell proliferation and invasion by targeting
SOCS4
.
...
PMID:miR-1290 promotes lung adenocarcinoma cell proliferation and invasion by targeting SOCS4. 2955 86